中国血液净化

中国血液净化 ›› 2017, Vol. 16 ›› Issue (12): 830-833.doi: 10.3969/j.issn.1671-4091.2017.012.009

• 综述 • 上一篇    下一篇

包裹性腹膜硬化症的治疗新进展

闵旭1,崔文鹏1,刘声茂1,刘树军1,苗里宁1   

  1. 1.  吉林大学白求恩第二医院肾病内科
  • 收稿日期:2017-08-24 修回日期:2017-10-12 出版日期:2017-12-12 发布日期:2017-12-18
  • 通讯作者: 苗里宁：miaolining55@163.com E-mail:miaolining55@163.com
  • 基金资助:

    ：吉林省省级科研课题(课题编号：2016J052；20150311082YY)

Advances in the treatment of encapsulating peritoneal sclerosis

  • Received:2017-08-24 Revised:2017-10-12 Online:2017-12-12 Published:2017-12-18
  • Contact: Lining Miao E-mail:miaolining55@163.com

PDF

677

摘要： 包裹性腹膜硬化症是长程腹膜透析罕见但严重的并发症，其发生率随腹膜透析治疗时间的延长而增加。包裹性腹膜硬化症早期临床表现往往不典型，缺乏特异性的诊断手段，进展至晚期主要表现为肠梗阻症状，死亡率较高。本文就近年来探讨包裹性腹膜硬化症治疗的相关文献进行综述，总结包裹性腹膜硬化症的治疗新进展。

关键词: 腹膜透析, 包裹性腹膜硬化症, 治疗

Abstract: Encapsulating peritoneal sclerosis (EPS) is a rare but serious complication in long-term peritoneal dialysis patients. The incidence of EPS increases with the duration of peritoneal dialysis treatment. In the early stage, the clinical manifestations tend to be atypical and few specific methods can be used for the diagnosis. When EPS develops to the end stage, it is characterized by intestinal obstruction and the mortality is extremely high. This article reviews the recent literature and summarizes the advances in the treatment of EPS.

Key words: Peritoneal dialysis, Encapsulating peritoneal sclerosis, Treatment